Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Metabolic Syndrome & Outcomes After CRC Surgery

Dis Colon Rectum; ePub 2019 Jan 31; Shariq, et al

There is an increased risk of 30-day postoperative renal complications, wound complications, and unplanned hospital readmissions in patients with metabolic syndrome undergoing elective surgery for colorectal cancer (CRC), a new study found. 30-day postoperative mortality and morbidity, unplanned reoperation, unplanned readmission, operative time, and length of stay (LOS) were measured. Among the findings:

  • Of 91,566 patients analyzed, 7,603 (8.3%) had metabolic syndrome.
  • Metabolic syndrome was associated with an increased risk of 30-day overall morbidity, pulmonary complications, renal complications, septic complications, cardiac complications, would complications, blood transfusion, longer LOS, and unplanned readmissions.
  • On multivariable analysis, metabolic syndrome remained significantly associated with renal complications, superficial surgical site infection, wound dehiscence, and unplanned readmissions.

Citation:

Shariq OA, Hanson KT, McKenna NP, et al. Does metabolic syndrome increase the risk of postoperative complications in patients undergoing colorectal cancer surgery? [Published online ahead of print January 31, 2019]. Dis Colon Rectum.